Orofaciodigital syndrome 3

From WikiMD's WELLNESSPEDIA

Other Names: OFD3; Oral-facial-digital syndrome type 3; OFD syndrome 3; Orofaciodigital syndrome III; Oral facial digital syndrome 3; Oral facial digital syndrome type 3; OFDS 3

Oral-facial-digital syndrome, type 3 is characterized by anomalies of the mouth, eyes and digits, associated with severe intellectual deficit.

Epidemiology[edit]

Five cases in two families have been reported (two males and three females).

Cause[edit]

The causative gene has not yet been identified.

Inheritance[edit]

Autosomal recessive inheritance, a 25% chance

Autosomal recessive inheritance has been suggested.

Signs and symptoms[edit]

Main clinical features include prominent forehead and occiput, round face with full cheeks, hypertelorism, esotropia, downslanting palpebral fissures, myoclonic twitching of the eyelids, conjugate deviation of the eyes, bifid uvula, pectus excavatum, short sternum, kyphosis, postaxial polydactyly, normal stature and severe spasticity.

For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. 30%-79% of people have these symptoms

5%-29% of people have these symptoms

Diagnosis[edit]

There are no specific tests to confirm diagnosis. However, diagnosis is generally made on the basis of clinical signs and symptoms.

Treatment[edit]

Treatment is supportive based on signs and symptoms. Genetic counselling is recommended for patients and their families. Treatment may involve reconstructive surgery for facial clefts.

NIH genetic and rare disease info[edit]

Orofaciodigital syndrome 3 is a rare disease.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.